J. Hoeg

发表

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

J. Mckenney, M. Weinstein, S. Grundy, 1993, JAMA.

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

Daniel Steinberg, D. Roger Illingworth, Gustav Schonfeld, 1988, Archives of internal medicine.

Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients.

B. McManus, W. Roberts, R. Gregg, 1984, The American journal of cardiology.

MPSA short communications

W. E. Moddeman, J. A. Lindquist, D. N. Perkins, 1988 .

Apolipoprotein B synthesis in humans: liver synthesizes only apolipoprotein B-100.

S. Edge, P. Schneider, H. Brewer, 1985, Metabolism: clinical and experimental.

An approach to the management of hyperlipoproteinemia.

R. Gregg, H. Brewer, J. Hoeg, 1986, JAMA.

Effects of combination cholestyramine-neomycin treatment on plasma lipoprotein concentrations in type II hyperlipoproteinemia.

K. Bailey, R. Gregg, H. Brewer, 1985, The American journal of cardiology.

Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin.

K. Bailey, R. Gregg, H. Brewer, 1984, Circulation.

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.

H. Brewer, J. Hoeg, N. Papadopoulos, 1985, Atherosclerosis.

Reverse Cholesterol Transport

J. Hoeg, A. Remaley, 1994 .

25 Reverse cholesterol transport

J. Hoeg, A. Remaley, 1994 .

Characterization of plasma lipids and lipoproteins in patients with beta 2-glycoprotein I (apolipoprotein H) deficiency.

R. Gregg, H. Brewer, J. Hoeg, 1985, Atherosclerosis.

Presence of two forms of apolipoprotein B in patients with dyslipoproteinemia.

R. Gregg, H. Brewer, E. Schaefer, 1983, Journal of lipid research.

Apolipoproteins and lipoproteins in human plasma: an overview.

R. Gregg, H. Brewer, J. Hoeg, 1988, Clinical chemistry.

Retroviral vector-mediated in vivo expression of low-density-lipoprotein receptors in the Watanabe heritable hyperlipidemic rabbit

K. Newman, D. Dichek, J. Hoeg, 1991, Somatic cell and molecular genetics.

Only in the Presence of Normal LDL Receptors in Transgenic Rabbits LCAT Modulates Atherogenic Plasma Lipoproteins and the Extent of Atherosclerosis

H. Brewer, J. Hoeg, E. Herderick, 2000 .

LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.

H. Brewer, J. Hoeg, E. Herderick, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase.

H. Brewer, J. Hoeg, J. Wang, 1998, Journal of lipid research.

Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.

R. F. Hoyt, J. Cornhill, J. Hoeg, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Adenoviral delivery of low-density lipoprotein receptors to hyperlipidemic rabbits: receptor expression modulates high-density lipoproteins.

H. Brewer, J. Hoeg, R. Shamburek, 1996, Metabolism: clinical and experimental.

Recent advances in lipoprotein metabolism and the genetic dyslipoproteinemias.

D. Rader, H. Brewer, J. Hoeg, 1991, Advances in experimental medicine and biology.

Differential tissue-specific expression of human apoA-I and apoA-II.

J. Hoeg, T. Eggerman, H. Brewer, 1991, Journal of lipid research.

Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function.

D. Rader, W. Gahl, J. Hoeg, 1991, The New England journal of medicine.

Definition and management of hyperlipoproteinemia.

J. Hoeg, H. Brewer, 1987, Journal of the American College of Nutrition.

Estimation of VLDL cholesterol in hyperlipidemia.

P. Wilson, R. Gregg, H. Brewer, 1985, Clinica chimica acta; international journal of clinical chemistry.

Risk factors for the development of premature cardiovascular disease.

R. Gregg, H. Brewer, J. Hoeg, 1985, Advances in experimental medicine and biology.

Mevinolin and Neomycin in the Treatment of Type II Hyperlipoproteinemia

K. Bailey, H. Brewer, J. Hoeg, 1987 .

The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemia.

K. Bailey, H. Brewer, J. Hoeg, 1986, Atherosclerosis.

The method of determination must be considered in interpreting blood cholesterol levels.

J. Hoeg, D. Blank, M. Kroll, 1986, JAMA.

Effect of low density lipoproteins, high density lipoproteins, and cholesterol on apolipoprotein A‐I mRNA in Hep G2 cells

H. Brewer, J. Hoeg, J. Monge, 1989, FEBS letters.

Cultured human hepatocytes. Evidence for metabolism of low density lipoproteins by a pathway independent of the classical low density lipoprotein receptor.

S. Edge, P. Schneider, T. Triche, 1986, The Journal of biological chemistry.

Active serum vitamin D levels are inversely correlated with coronary calcification.

K. Watson, J. Hoeg, L. Demer, 1997, Circulation.

Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia.

J. Hoeg, I. Feuerstein, E. Tucker, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Tissue-specific expression of apolipoprotein A-I (ApoA-I) is regulated by the 5'-flanking region of the human ApoA-I gene.

H. Brewer, J. Hoeg, K. Higuchi, 1988, The Journal of biological chemistry.

Human apolipoprotein A-I. Post-translational modification by covalent phosphorylation.

J. Hoeg, Z. Beg, S. Demosky, 1989, The Journal of biological chemistry.

Human apolipoprotein A-I. Post-translational modification by fatty acid acylation.

H. Brewer, J. Hoeg, R. Ronan, 1986, The Journal of biological chemistry.

Distinct hepatic receptors for low density lipoprotein and apolipoprotein E in humans.

R. Gregg, H. Brewer, E. Schaefer, 1985, Science.

Low-Density Lipoprotein Receptor and Apolipoprotein A-I and B Expression in Human Enterocytes

D. Sviridov, H. Brewer, J. Hoeg, 2003, Digestion.

Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.

H. Brewer, J. Hoeg, A. Bérard, 1996, The Journal of clinical investigation.

Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner.

H. Brewer, J. Hoeg, A. Bérard, 1997, Journal of lipid research.

Pharmacologic and Surgical Treatment of Dyslipidemic Children and Adolescents

J. Hoeg, 1991, Annals of the New York Academy of Sciences.

Characterization of a Human Hepatic Receptor for High Density Lipoproteins

S. Edge, R. Gregg, J. Hoeg, 1985, Arteriosclerosis.

The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.

D. Rader, J. Hoeg, M. Grossman, 1995, The Journal of clinical investigation.

Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.

T. Starzl, E. Schaefer, J. Hoeg, 1984, The Journal of clinical investigation.

The effect of mevinolin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway.

G. Chrousos, J. Hoeg, K. Barnes, 1987, The Journal of clinical endocrinology and metabolism.

Apolipoprotein B mRNA Editing: Modulation and Clinical Implications

D. Rader, J. Hoeg, T. Eggerman, 1993 .

Aberrant hy pot halam ic-pi t ui tary-ovarian axis i n the Watanabe heritable hyperlipidemic rabbit

J. Hoeg, L. Nelson, E. D. Robins, 1994 .

Apolipoprotein B synthesized by Hep G2 cells undergoes fatty acid acylation.

J. Hoeg, S. Demosky, H. Brewer, 1988, Journal of lipid research.

Role of Gene Therapy in the Treatment of the Genetic Dyslipoproteinemias

H. Brewer, J. Hoeg, S. Santamarina-Fojo, 1996 .

Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).

R. Gregg, H. Brewer, J. Hoeg, 1995, The Journal of clinical investigation.

The expressed human hepatic receptor for low-density lipoproteins differs from the fibroblast low-density lipoprotein receptor.

J. Hoeg, K. Lackner, J. C. Osborne, 1986, Biochimica et biophysica acta.

Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects.

S. Edge, T. Starzl, T. Triche, 1986, Biochimica et biophysica acta.

The effect of portacaval shunt on hepatic lipoprotein metabolism in familial hypercholesterolemia.

T. Starzl, E. Schaefer, J. Hoeg, 1985, The Journal of surgical research.

Transgenic rabbits as models for atherosclerosis research.

J. Hoeg, M. Brousseau, J. Hoeg, 1999, Journal of lipid research.

Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia.

T. Triche, R. Gregg, H. Brewer, 1986, The Journal of clinical investigation.

Identification of novel differentially expressed hepatic genes in cholesterol-fed rabbits by a non-targeted gene approach.

J. Hoeg, A. Remaley, U. Schumacher, 1995, Journal of lipid research.

O-linked glycosylation modifies the association of apolipoprotein A-II to high density lipoproteins.

J. Hoeg, A. Remaley, U. Schumacher, 1993, The Journal of biological chemistry.

Heterogeneity of lipoprotein electrophoretic patterns in patients with type IIa hyperlipoproteinemia.

R. Gregg, J. Hoeg, H. Brewer, 1983, Clinical chemistry.

Lecithin:Cholesterol Acyltransferase Overexpression Generates Hyperalpha-lipoproteinemia and a Nonatherogenic Lipoprotein Pattern in Transgenic Rabbits (*)

R. F. Hoyt, J. Hoeg, A. Bérard, 1996, The Journal of Biological Chemistry.

Evaluation of urinary cells in acid cholesteryl ester hydrolase deficiency

H. Brewer, J. Hoeg, P. Kwiterovich, 1986, Clinical genetics.

Enhanced apolipoprotein E production with normal hepatic mRNA levels in the Watanabe heritable hyperlipidemic rabbit.

R. Gregg, H. Brewer, J. Hoeg, 1988, Arteriosclerosis.

Familial Hypercholesterolemia: What the Zebra Can Teach Us About the Horse

J. Hoeg, J. Hoeg, 1994 .

Homozygous familial hypercholesterolemia: a paradigm for phenotypic variation.

J. Hoeg, 1993, The American journal of cardiology.

Vitamin A and vitamin E replacement in abetalipoproteinemia.

H. Brewer, E. Schaefer, J. Hoeg, 1984, Annals of internal medicine.

Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia.

T. Starzl, J. Hoeg, H. Brewer, 1987, The American journal of cardiology.

The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia.

R. Gregg, H. Brewer, E. Lakatos, 1985, Metabolism: clinical and experimental.

Impaired adrenal reserve in the Watanabe Heritable Hyperlipidemic rabbit: implications for LDL-receptor function in steroidogenesis.

W. Green, R. Gregg, H. Brewer, 1985, Metabolism: clinical and experimental.

Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man.

R. Gregg, J. Hoeg, J. C. Osborne, 1983, The American journal of medicine.

Homozygous hypobetalipoproteinemia: transcriptional regulation and 5'-flanking sequence analysis in an apolipoprotein B deficiency state.

R. Gregg, H. Brewer, J. Hoeg, 1989, Biochimica et biophysica acta.

Successful treatment of angina pectoris with liver transplantation and bilateral internal mammary bypass graft surgery in familial hypercholesterolemia.

T. Starzl, M. Leon, J. Hoeg, 1988 .

Multiple flexor tendon xanthomas and contractures in the hands of a child with familial hypercholesterolemia.

J. Hoeg, H. Kruth, S. Gunther, 1986, The Journal of hand surgery.

Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin.

H. Brewer, J. Hoeg, E. Brittain, 1987, Journal of Clinical Endocrinology and Metabolism.

Characterization of plasma lipids and lipoproteins in cholesteryl ester storage disease.

J. Hoeg, S. Demosky, H. Brewer, 1985, Biochemical medicine.

ilation in Hypercholesterolemic Patients

J. Hoeg, J. Panza, M. Kilcoyne, 2016 .

Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis.

R. D'Agostino, P. Wolf, P. Wilson, 1997, The New England journal of medicine.

Quantitation of Plasma Apolipoproteins in the Primary and Secondary Prevention of Coronary Artery Disease

D. Rader, J. Hoeg, H. Brewer, 1994, Annals of Internal Medicine.

Filipin as a flow microfluorometry probe for cellular cholesterol.

J. Hoeg, D. Stephany, J. Wunderlich, 1984, Cytometry.

Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency.

J. Hoeg, O. Pescovitz, S. Demosky, 1984, American journal of human genetics.

Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.

W. Gahl, M. Dalakas, J. Hoeg, 1988, The Journal of clinical investigation.

Normalization ofplasma lipoprotein concentrations inpatients withtype II hyperlipoprotein emia

K. Bailey, R. Gregg, J. Hoeg, 1984 .

The Management of Hyperlipoproteinemia-Reply

R. Gregg, H. Brewer, J. Hoeg, 1986 .

Post-Translational Modification by Covalent Phosphorylation of Human Apolipoprotein B-100

H. Brewer, J. Hoeg, Z. Beg, 1995 .

Altered compliance and residual strain precede angiographically detectable early atherosclerosis in low-density lipoprotein receptor deficiency.

R. F. Hoyt, J. Cornhill, M. Leon, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Evaluating coronary heart disease risk. Tiles in the mosaic.

J. Hoeg, 1997, JAMA.

Characterization of neutral and acid ester hydrolase in Wolman's disease.

H. Brewer, J. Hoeg, S. Demosky, 1982, Biochimica et biophysica acta.

3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia.

J. Hoeg, H. Brewer, J. Hoeg, 1987, JAMA.

Ontogenetic regulation of apolipoprotein B mRNA editing during human and rat development in vivo.

J. Hoeg, H. Brewer, A. Patterson, 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine.

M. B. Kuberger, D. Sviridov, J. Hoeg, 1990, Journal of lipid research.

Neomycin and plasma lipoproteins in type II hyperlipoproteinemia

K. Bailey, P. Wilson, R. Gregg, 1984, Clinical pharmacology and therapeutics.

Superovulation of rabbits with FSH alters in vivo development of vitrified morulae.

J. Hoeg, W. Rall, R. Kauffman, 1998, Theriogenology.

The use of parenteral hyperalimentation and elemental formula feeding in the treatment of Wolman disease

H. Brewer, J. Hoeg, S. Demosky, 1985 .

Cholesteryl ester storage disease: Hepatopathology and effects of therapy with lovastatin

K. Ishak, J. Hoeg, A. D. Di Bisceglie, 1990, Hepatology.

Regulation of LDL receptor, apoB, and apoE protein and mRNA in Hep G2 cells.

J. Hoeg, K. Schumacher, S. Demosky, 1992, DNA and cell biology.

Genomic Structure, Biosynthesis, and Processing of Preproapolipoprotein C-II

H. Brewer, J. Hoeg, D. Sprecher, 1987 .

Lipoproteins and atherogenesis.

J. Hoeg, J M Hoeg, J. Hoeg, 1998, Endocrinology and metabolism clinics of North America.

Overexpression of Human Lecithin Cholesterol Acyltransferase Leads to Hyperalphalipoproteinemia in Transgenic Mice (*)

R. F. Hoyt, H. Klein, H. Brewer, 1995, The Journal of Biological Chemistry.

Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis.

J. Hoeg, G. Lambert, S. Santamarina-Fojo, 2000, Current opinion in lipidology.

Gene therapy for the genetic dyslipoproteinaemias

H. Brewer, J. Hoeg, N. Maeda, 1995 .

Can genes prevent atherosclerosis?

J. Hoeg, 1996, JAMA.

Apolipoprotein B upstream suppressor site: identification of an element which can decrease apolipoprotein B transcription.

J. Hoeg, A. Li, U. Schumacher, 1991, Biochemical and biophysical research communications.

Comparison of six pharmacologic regimens for hypercholesterolemia.

K. Bailey, H. Brewer, J. Hoeg, 1987, The American journal of cardiology.

Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia.

K. Bailey, R. Gregg, J. Hoeg, 1986, The American journal of cardiology.

Lcat overexpression in different animal models: modulation of atherosclerosis by CETP, HL and apoA-1

H. Brewer, J. Hoeg, C. Koch, 1999 .

The Role of Apolipoprotein E and the Low-Density Lipoprotein Receptor in Modulating the in Vivo Metabolism of Apolipoprotein-B-Containing Lipoproteins

R. Gregg, H. Brewer, J. Hoeg, 1987 .

Human preproapolipoprotein C-II. Analysis of major plasma isoforms.

H. Brewer, J. Hoeg, D. Sprecher, 1986, The Journal of biological chemistry.

Differential rate of cholesterol efflux from the apical and basolateral membranes of MDCK cells.

J. Hoeg, A. Remaley, A. Shirali, 1998, Journal of lipid research.

Polarized secretion of apoA-I and apoA-II by transfected MDCK cells.

J. Hoeg, A. Remaley, 1995, Journal of lipid research.

Carboxyl-terminal Domain Truncation Alters Apolipoprotein A-I in Vivo Catabolism (*)

H. Brewer, J. Hoeg, A. Remaley, 1995, The Journal of Biological Chemistry.

Isoforms of apolipoprotein A-II in human plasma and thoracic duct lymph. Identification of proapolipoprotein A-II and sialic acid-containing isoforms.

S. Edge, R. Gregg, J. Hoeg, 1985, The Journal of biological chemistry.

Estrogen attenuation of the development of hypertension in spontaneously hypertensive rats.

J. Hoeg, M. Weinberger, L. R. Willis, 1977, The American journal of physiology.

Guidelines for trials of gene therapy and somatic gene therapy in cardiovascular disease.

J. Hoeg, 1998, The American journal of cardiology.

In vivo alteration of a mutant human protein using the free thiol cysteamine.

R. Gregg, W. Gahl, J. Hoeg, 1985, American journal of medical genetics.

Aberrant hypothalamic-pituitary-ovarian axis in the Watanabe heritable hyperlipidemic rabbit.

J. Hoeg, L. Nelson, E. D. Robins, 1994, Journal of lipid research.

latrogenic hyperlipidaemia with GM1 ganglioside

J. Hoeg, I. Linfante, M. Mouradian, 1993, The Lancet.

A genetic therapy for familial hypercholesterolemia.

K. Newman, D. Dichek, J. Hoeg, 1990, Transactions of the Association of American Physicians.

Fractal analysis of virtual endoscopy reconstructions

Ronald M. Summers, James D. Malley, Lynne M. Pusanik, 1999, Medical Imaging.

Effect of oral neomycin treatment of hyperlipoproteinemia on antibiotic susceptibilities of stool enteric flora.

J. Hoeg, F. Witebsky, T. Wu, 1986, American Journal of Cardiology.

HMG-CoA reductase inhibitors

J. Hoeg, 1990 .

Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia.

R M Summers, R. Summers, T. Spray, 1998, Circulation.

Human lipoprotein metabolism and the liver.

J. Hoeg, H. Brewer, 1986, Progress in liver diseases.

Isolation of Novel Genes Regulated by Dietary Cholesterol by a Pcr-Based Subtraction Library

H. Brewer, J. Hoeg, A. Remaley, 1995 .

Abnormal growth hormone secretory dynamics in children with familial hypercholesterolemia.

G. Chrousos, J. Hoeg, J. Ross, 1988, Hormone research.